European agency recommends Novo hemophilia drug for approval

 European agency recommends Novo hemophilia drug for approval

European agency recommends Novo hemophilia drug for approval

European agency recommends Novo hemophilia drug for approval

 

NBN Infusions delivers comprehensive services to patients of all ages, from pediatric to geriatric, providing a full range of care for Home Infusion Therapy. NBN Infusions on-site, licensed pharmacy can provide prescription medications, equipment, supplies and skilled nursing care needed for Home Infusion Therapy.

 

Home Infusion Therapy is a more convenient and cost-effective option than traditional inpatient therapy, with care administered in the comfortable surroundings of one’s own home. Home Infusion Therapy allows for a more active role in one’s own health care. It can also ease stress and anxiety that is sometimes associated with inpatient treatment, resulting in better patient outcomes.

 

COPENHAGEN (Reuters) – Danish insulin maker Novo Nordisk has received a recommendation for marketing approval from a European Medicines Agency (EMA) committee for its hemophilia treatment turoctocog alfa.

 

The company said on Friday the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the drug, also known as NovoEight, which belongs to a class of hemophilia drugs called factor 8.

 

“We are very happy to now have treatment in this mainstream hemophilia market, which we have never had before,” said Chief Science Officer Mads Krogsgaard Thomsen.

 

Thomsen said the total market for factor 8 hemophilia is worth 35-40 billion Danish crowns ($6.36 billion to $7.26 billion) in terms of sales.

 

He said the company expects to receive final marketing authorization from the European Commission in two to three months.

 

The company said in the statement it expects to launch the drug in Europe early next year.

 

NovoEight has also been filed for marketing authorization in the United States, Japan, Australia and Switzerland.

 

($1 = 5.5067 Danish crowns)

 

(Reporting by Mette Fraende and Shida Chayesteh; Editing by Elaine Hardcastle)

 

Originally posted by Yahoo News 

 

If you would like to know more about hemophilia contact NBN Infusions.

 

[contact-form][contact-field label=’Name’ type=’name’ required=’1’/][contact-field label=’Email’ type=’email’ required=’1’/][contact-field label=’Telephone’ type=’text’ required=’1’/][/contact-form]

Enhanced by Zemanta